Last updated: 30 June 2021 at 4:55pm EST

Howard Liang Net Worth




The estimated Net Worth of Howard Liang is at least $9.81 Million dollars as of 14 January 2021. Howard Liang owns over 14,000 units of BeiGene Ltd stock worth over $2,660,490 and over the last 9 years Howard sold BGNE stock worth over $7,152,582.

Howard Liang BGNE stock SEC Form 4 insiders trading

Howard has made over 16 trades of the BeiGene Ltd stock since 2016, according to the Form 4 filled with the SEC. Most recently Howard sold 446 units of BGNE stock worth $162,790 on 28 June 2021.

The largest trade Howard's ever made was exercising 1,497,200 units of BeiGene Ltd stock on 14 December 2020 worth over $1,302,564. On average, Howard trades about 80,337 units every 89 days since 2016. As of 14 January 2021 Howard still owns at least 12,600 units of BeiGene Ltd stock.

You can see the complete history of Howard Liang stock trades at the bottom of the page.



What's Howard Liang's mailing address?

Howard's mailing address filed with the SEC is C/O MOURANT GOVERNANCE SERVICES (CAYMAN), 94 SOLARIS AVENUE, CAMANA BAY, GRAND CAYMAN, E9, KY1-1108.

Insiders trading at BeiGene Ltd

Over the last 9 years, insiders at BeiGene Ltd have traded over $1,899,158,980 worth of BeiGene Ltd stock and bought 23,241,738 units worth $1,040,248,444 . The most active insiders traders include Bros. Advisors Lp667, L.P.B..., Investment Management, Ltd...., and Bros. Advisors Lp Baker Bro.... On average, BeiGene Ltd executives and independent directors trade stock every 13 days with the average trade being worth of $33,382,815. The most recent stock trade was executed by Xiaobin Wu on 3 September 2024, trading 5,556 units of BGNE stock currently worth $1,053,695.



What does BeiGene Ltd do?

BeiGene is a biotechnology company that specializes in the development of drugs for cancer treatment. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib.



What does BeiGene Ltd's logo look like?

BeiGene Ltd logo

Complete history of Howard Liang stock trades at BeiGene Ltd

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
28 Jun 2021 Howard Liang
CFO and Chief Strategy Officer
Sale 446 $365.00 $162,790
28 Jun 2021
0
18 Jun 2021 Howard Liang
CFO and Chief Strategy Officer
Sale 486 $325.89 $158,383
18 Jun 2021
0
7 Jun 2021 Howard Liang
CFO and Chief Strategy Officer
Sale 650 $354.16 $230,204
7 Jun 2021
0
14 Jan 2021 Howard Liang
CFO and Chief Strategy Officer
Option 14,000 $6.50 $91,000
14 Jan 2021
12,600
14 Dec 2020 Howard Liang
CFO and Chief Strategy Officer
Option 1,497,200 $0.87 $1,302,564
14 Dec 2020
91,900
5 Oct 2020 Howard Liang
CFO and Chief Strategy Officer
Option 14,000 $6.50 $91,000
5 Oct 2020
14,000
14 Sep 2020 Howard Liang
CFO and Chief Strategy Officer
Option 14,000 $6.50 $91,000
14 Sep 2020
14,000
29 Jun 2020 Howard Liang
CFO and Chief Strategy Officer
Sale 300 $191.23 $57,369
29 Jun 2020
0
8 Jun 2020 Howard Liang
CFO and Chief Strategy Officer
Sale 453 $170.84 $77,391
8 Jun 2020
0
18 Nov 2019 Howard Liang
CFO and Chief Strategy Officer
Option 25,000 $6.50 $162,500
18 Nov 2019
25,000
27 Jun 2019 Howard Liang
CFO and Chief Strategy Officer
Sale 5,876 $9.47 $55,646
27 Jun 2019
122,317
21 May 2019 Howard Liang
CFO and Chief Strategy Officer
Option 23,200 $6.50 $150,800
21 May 2019
23,200
6 May 2019 Howard Liang
CFO and Chief Strategy Officer
Option 1,800 $6.50 $11,700
6 May 2019
1,800
16 Mar 2018 Howard Liang
CFO and Chief Strategy Officer
Sale 40,000 $160.27 $6,410,800
16 Mar 2018
0
8 Feb 2016 Howard Liang
CFO and Chief Strategy Officer
Buy 65,000 $1.85 $120,250
8 Feb 2016
65,000
8 Feb 2016 Howard Liang
CFO and Chief Strategy Officer
Buy 65,000 $1.85 $120,250
8 Feb 2016
65,000


BeiGene Ltd executives and stock owners

BeiGene Ltd executives and other stock owners filed with the SEC include: